risks of glp 1 agonists The promise and peril GLP-1 agonists: What we do (and don't) know as of August 2024 What Are GLP-1 Agonists For

As a result, the safety and tolerability profile of retatrutide aligns with other incretin-based therapies (hormones produced by the gut that help regulate blood sugar levels)

These clocks detect DNA methylation, chemical marks on DNA that help regulate how genes are turned on or off without changing the genetic sequence itself

Due to their diverse structures, the pharmacokinetic profiles vary, and a prolonged half-life may be associated with an increased risk of adverse events

Also, obesity hurts the heart, kidneys, liver, and mental health

1 With the possible exception of Operation Warp Speed, GLP-1 therapies have defined the decade in terms of impact on population health